Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis

Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis

Secondary amyloid A (AA) amyloidosis is a late and serious complication of poorly controlled, chronic inflammatory diseases. Rheumatoid arthritis (RA) patients with poorly controlled, longstanding disease and those with extra-articular manifestations are under risk for the development of AA amyloido...

Full description

Bibliographic Details
Main Authors: Levent Kilic, Abdulsamet Erden, Yusuf Ziya Sener, Berkan Armagan, Alper Sari, Umut Kalyoncu, Omer Karadag, Ali Akdogan, Ismail Dogan, Sule Apras Bilgen, Sedat Kiraz, Ihsan Ertenli
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:Biomolecules
Subjects:
rituximab
amyloidosis
rheumatoid arthritis
biologic registry
proteinuria
Online Access:https://www.mdpi.com/2218-273X/8/4/136

Internet

https://www.mdpi.com/2218-273X/8/4/136

Similar Items